Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Cancer Discovery|July 25, 2020
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable DependenciesBriana C Prager, Harish N Vasudevan, Deobrat Dixit, et al.Cancer Cell|January 1, 2019
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene RegulationSerap Erkek, Pascal D Johann, Martina A Finetti, et al.Developmental Cell|June 4, 2024
Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progressionRyo Shiraishi, Gabriele Cancila, Kohei Kumegawa, et al.Nature Medicine|October 24, 2018
A biobank of patient-derived pediatric brain tumor modelsSebastian Brabetz, Sarah E S Leary, Susanne N Gröbner, et al.The Journal of Experimental Medicine|April 6, 2019
Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastomaStephen C Mack, Irtisha Singh, Xiuxing Wang, et al.Cancer Discovery|October 7, 2021
Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem CellsZhixin Qiu, Linjie Zhao, Jia Z Shen, et al.Nature Communications|July 22, 2018
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastomaMatija Snuderl, Kasthuri Kannan, Elke Pfaff, et al.Nature Communications|September 4, 2019
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesisKristian W Pajtler, Yiju Wei, Konstantin Okonechnikov, et al.Nature|December 21, 2017
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profilingStephen C Mack, Kristian W Pajtler, Lukas Chavez, et al.Communications Biology|October 16, 2020
Network integration and modelling of dynamic drug responses at multi-omics levelsNathalie Selevsek, Florian Caiment, Ramona Nudischer, et al.Pageof 11